Treatment and Prevention of Rh Isoimmunization
Open Access
- 1 June 2014
- journal article
- Published by Georg Thieme Verlag KG in Journal of Fetal Medicine
- Vol. 01 (02) , 81-88
Abstract
Rhesus (Rh) isoimmunization is an important clinical entity in India and other developing countries, which is responsible for fetal anemia and hydrops fetalis, and if not treated, it can result in intrauterine fetal demise. Rh isoimmunization is responsible for severe jaundice in neonates, which can be severe enough to cause kernicterus with debilitating consequences, if not treated adequately. It can be prevented with simple measures and treated if recognized in time.Keywords
This publication has 17 references indexed in Scilit:
- Detection of fetomaternal hemorrhageAmerican Journal of Hematology, 2012
- Techniques of intrauterine fetal transfusion for women with red-cell isoimmunisation for improving health outcomes2010
- Fetal middle cerebral artery Doppler velocimetry in cases of rhesus alloimmunizationThe Journal of Maternal-Fetal & Neonatal Medicine, 2008
- ACOG Practice Bulletin No. 75: Management of AlloimmunizationObstetrics & Gynecology, 2006
- Prediction of fetal anemia in pregnancies with red‐cell alloimmunization: comparison of middle cerebral artery peak systolic velocity and amniotic fluid OD450Ultrasound in Obstetrics & Gynecology, 2005
- Prevention and management of RhD isoimmunizationClinics in Perinatology, 2004
- Anti-D administration in pregnancy for preventing Rhesus alloimmunisation1999
- ABC of transfusion. Haemolytic disease of the newborn and its prevention.BMJ, 1990
- Rh Disease: Intravascular Fetal Blood Transfusion by CordocentesisFetal Diagnosis and Therapy, 1986
- Recognition of the hydropic fetus by gray scale ultrasoundJournal of Clinical Ultrasound, 1976